Revenio Group Oyj - Company Announcement

Revenio Group Corporation: CLARIFICATION OF THE SCHEDULE OF CAPITAL REPAYMENT RESOLVED AUGUST 5th 2013

Revenio Group Oyj Stock Exchange Release, August 5, 2013 at 12.00 a.m.

CLARIFICATION OF THE SCHEDULE OF CAPITAL REPAYMENT RESOLVED  AUGUST  5th 2013

The ex-date of the capital repayment resolved on August 5th 2013 is August
6(th) 2013. As informed earlier, those entitled to the capital repayment are the
shareholders listed in the company's share register maintained by Euroclear
Finland on  August 8(th) 2013


Olli-Pekka Salovaara
President and CEO

For further information, please contact:

CFO Pekka Raatikainen,
+358 (0)50 553 4094 (mobile)
pekka.raatikainen@revenio.fi
http://www.revenio.fi/

DISTRIBUTION:

NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
Key media
www.revenio.fi

The Revenio Group in brief

Revenio is a Finnish health tech group whose core business are tonometers. The
Revenio Health Tech segment comprises the operations of Icare Finland Oy. The
widely patented Icare product family is the current cornerstone of the Group's
success. Revenio seeks vigorous growth in health technology, both organically
and through acquisitions and mergers.

The Revenio Group also includes other business operations, which are grouped
under the Technology and Services segment. This segment's operations have a
shared global market and represent the cutting edge of technology products and
services in their industry. These businesses are extremely profitable in their
industries and generate positive cash flow.

In 2012, the Revenio Group's net sales totaled EUR 25.4 million, with its
operating margin standing at 19.4 percent. The Revenio Group Corporation is
listed on NASDAQ OMX Helsinki.


[HUG#1721126]